1 minute read

BlueCross residents get COVID-19 vaccine

"I'm at a vulnerable age. I felt that for my safety and wellbeing, getting the vaccine was for me. I had no apprehensive feelings at all," said Florence. “My family is supportive of me getting the vaccine and are also getting it themselves. We are all in unison on that.”

Apart from some tenderness at the injection site on her arm, Florence did not experience any other side effects. “I didn’t even feel the needle going in,” she said.

Advertisement

To those who are fearful or have doubts about the vaccine, Florence said people are fortunate and privileged to be living in Australia and have access to the vaccine to keep everyone safe. While residents were given priority to receive the COVID-19 vaccine, some staff members also took up the opportunity to receive the vaccine from the excess stock on vaccination day.

“We know that residents at other BlueCross residences are also waiting for their opportunity to be vaccinated. The rollout is managed at a federal government level and we are working closely with the health authorities to expedite the process,” said Ingrid Harvey, Chief Operating Officer.

The more residents and staff who are vaccinated, the greater our ability to keep our residents safe and for everyone to live as normal a life as possible. "

While the decision to receive the COVID-19 vaccine is entirely voluntary, BlueCross strongly encourages all residents and staff to be vaccinated as part of the Government program. None of the COVID-19 vaccines approved for use in Australia contain a live virus that can cause COVID-19.

Like any other vaccinations, some people may experience minor side effects such as pain, redness and/or swelling at the injection site, mild fever or headache. For BlueCross residents who received the COVID-19 vaccine, no significant reactions have been reported.

Anyone with concerns about the suitability of the COVID-19 vaccine is recommended to speak to a general practitioner or health professional so they can make an informed decision.

Robert Putamorsi Chief Executive Officer

This article is from: